|
" High-throughput RNAi screening "
editors, David O. Azorsa, Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona, USA ; Shilpi Arora, Constellation Pharmaceuticals, Cambridge, Massachusetts, USA.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
569192
|
| Doc. No
|
:
|
b398411
|
| Title & Author
|
:
|
High-throughput RNAi screening : methods and protocols /\ editors, David O. Azorsa, Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona, USA ; Shilpi Arora, Constellation Pharmaceuticals, Cambridge, Massachusetts, USA.
|
| Publication Statement
|
:
|
New York :: Humana Press,, [2016]
|
| Series Statement
|
:
|
Methods in molecular biology,; 1470
|
|
|
:
|
Springer protocols
|
| ISBN
|
:
|
9781493963355
|
|
|
:
|
: 149396335X
|
|
|
:
|
9781493963379
|
|
|
:
|
1493963376
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Abstract
|
:
|
High-throughput RNAi screening remains one of the most widely used technologies to perform target identification and validation studies in an unbiased manner. These assays are equally important for research and development across academic, biotech, and pharmaceutical industries.--
|
| Subject
|
:
|
RNA interference, Laboratory manuals.
|
| Subject
|
:
|
High throughput screening (Drug development), Laboratory manuals.
|
| Subject
|
:
|
RNA Interference.
|
| Subject
|
:
|
Drug Evaluation, Preclinical-- methods.
|
| Subject
|
:
|
Drug Discovery.
|
| Added Entry
|
:
|
Azorsa, David O.
|
|
|
:
|
Arora, Shilpi.
|
| |